Swamy Khoday News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Swamy khoday. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Swamy Khoday Today - Breaking & Trending Today

Khoday's Viranorm, Latest Ayurvedic Immunity Boosting Antiviral Drug For COVID Treatment


Khoday s Viranorm, Latest Ayurvedic Immunity Boosting Antiviral Drug For COVID Treatment
May 17, 2021, 18:59 IST
The Khoday Group has released an ayurvedic medication for the treatment of Covid.
Bengaluru: Bengaluru-based Khoday Group has developed an ayurvedic immunity-boosting drug that is currently being tested in various hospitals.
Around 250 Covid patients are currently being screened on ViraNorm in Victoria and other hospitals. The third stage of the trial for ViraNorm, which was produced in collaboration with Althea DRF and Lifesciences, has been completed.
In the presence of Dr. K G Padmanabhan and Dr. Radhashyam Naik, Khoday Group managing director Swamy Khoday published ViraNorm in tablet shape on Saturday. ....

Radhashyam Naik , Swamy Khoday , Khoday Group , Bengaluru Based Khoday Group , Khoday Group , Covid Treatment , Khoday 039s Viranorm , Ntiviral Drug For Covid , Covid Medicines , Tablet Vaccine , Engaluru Khoday , கோடாய் குழு ,

Khoday Group, Dabur Research Foundation launches 'ViraNorm' to fight Covid-19


The drug is add-on therapy for asymptomatic and symptomatic Covid patients.
Khoday Group of Industries, a Bengaluru based company, has rolled out ViraNorm - ayurvedic immuno-modulator, which helps treat Covid-19 patients. Through the launch of ‘ViraNorm’, Khoday Group is entering the alternative medicine sector.
The drug ‘ViraNorm’ has been developed by Khoday Group in collaboration with Athera Dabur Research Foundation (DRF) LifeSciences.
According to the company, ‘ViraNorm’ has undergone Phase 3 clinical trials in the country for an ayurvedic formulation and conducted according to international standards of good clinical trials and is found to be effective in clinical trials and has been launched after subjecting it, thorough efficacy and safety studies. It helps to halt the progression of viruses in the body. So, this can be referred as an add-on therapy/medication for asymptomatic and symptomatic Covid patients. This helps in stopping the migration ....

Swamy Khoday , Khoday Group Of Industries , Khoday Group , Athera Dabur Research Foundation , World Health Organization , National Accreditation Board For Hospitals , Cellular Level Inflammation , Cell Mediated , Manu Jaggi , Chief Operating Officer , Clinical Trials , Victoria Hospital , National Accreditation Board , Vice Chairman , Managing Director , Dabur Research Foundation , Covid 19 , Ayurvedic Medicine , Ayurvedic Immuno Modulator , கோடாய் குழு , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , தேசிய அங்கீகாரம் பலகை க்கு மருத்துவமனைகள் , செல் மத்தியஸ்தம் , தலைமை இயங்குகிறது அதிகாரி , மருத்துவ சோதனைகள் , விக்டோரியா மருத்துவமனை ,